0001127602-24-013566.txt : 20240429 0001127602-24-013566.hdr.sgml : 20240429 20240429164957 ACCESSION NUMBER: 0001127602-24-013566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240425 FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Jason R CENTRAL INDEX KEY: 0001845677 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40097 FILM NUMBER: 24892055 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: C/O CORVEX MANAGEMENT LP CITY: NEW YORK STATE: NY ZIP: 10065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc. CENTRAL INDEX KEY: 0001830214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 872652913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (877) 442-5362 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp. DATE OF NAME CHANGE: 20210210 FORMER COMPANY: FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp. DATE OF NAME CHANGE: 20201027 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-04-25 0001830214 Ginkgo Bioworks Holdings, Inc. DNA 0001845677 Kelly Jason R C/O GINKGO BIOWORKS HOLDINGS 27 DRYDOCK AVENUE BOSTON MA 02210 1 1 See remarks 0 Stock Option 2.50 2024-04-25 4 A 0 5000000 0 A 2034-04-25 Class A Common Stock 5000000 5000000 D The options are subject both to time-based and performance-based vesting criteria (the "Founder Options"). The performance-based vesting is tied to the achievement of four specified stock price hurdles within a five-year period, with 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $5.00, 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $7.50, 20% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $10.00 and the remaining 60% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $12.50. If any of the performance-based criteria are achieved during the five-year performance period, the awards will vest on the five-year anniversary of the grant date, subject to the Reporting Person's continued employment with Ginkgo on such anniversary. CEO & Founder /s/ Karen Tepichin, Attorney-in-Fact 2024-04-29